Cell specific single viral vector CRISPR/Cas9 editing and genetically encoded tool delivery in the central and peripheral nervous systems
Jamie C. MoffaiD, India N. Bland, Jessica R. TooleyiD, Vani Kalyanaraman, Monique R. Heitmeier, Meaghan C. CreediD, Bryan A. CopitsiD
Abstract
Gene manipulation strategies using germline knockout, conditional knockout, and more recently CRISPR/Cas9 are crucial tools for advancing our understanding of the nervous system. However, traditional gene knockout approaches can be costly and time consuming, may lack cell-type specificity, and can induce germline recombination. Viral gene editing presents and an exciting alternative to more rapidly study genes of unknown function; however, current strategies to also manipulate or visualize edited cells are challenging due to the large size of Cas9 proteins and the limited packaging capacity of adeno-associated viruses (AAVs). To overcome these constraints, we have developed an alternative gene editing strategy using a single AAV vector and mouse lines that express Cre-dependent Cas9 to achieve efficient cell-type specific editing across the nervous system. Expressing Cre-dependent Cas9 in specific cell types in transgenic mouse lines affords more space to package guide RNAs for gene editing together with Cre-dependent, genetically encoded tools to manipulate, map, or monitor neurons using a single virus. We validated this strategy with three commonly used tools in neuroscience: ChRonos, a channelrhodopsin, for manipulating synaptic transmission using optogenetics; GCaMP8f for recording Ca2+ transients using fiber photometry, and mCherry for anatomical tracing of axonal projections. We tested these tools in multiple brain regions and cell types, including GABAergic neurons in the nucleus accumbens (NAc), glutamatergic neurons projecting from the ventral pallidum (VP) to the lateral habenula (LHb), dopaminergic neurons in the ventral tegmental area (VTA), and parvalbumin (PV)-positive proprioceptive neurons in the periphery. This flexible approach should be useful to identify novel genes that affect synaptic transmission, circuit activity, or morphology with a single viral injection.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 5
- FWCI
- 0.68
- Field percentile
- top 37%
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Efficient in vivo neuronal genome editing in the mouse brain using nanocapsules containing CRISPR-Cas9 ribonucleoproteins
Jeanette M. Metzger, Yuyuan Wang, … Shaoqin Gong·bioRxiv·Jul 24, 2022
- Genome editing in the mouse brain with minimally immunogenic Cas9 RNPs
E. C. Stahl, J. K. Sabo, … J. A. Doudna·bioRxiv·Apr 13, 2023
- Circuit-specific gene editing for precision modulation of neuronal activity with CRISPR-rabies virus
Zijian Zhang, Jing Xu, … Dmitry Velmeshev·bioRxiv·Nov 3, 2025
- Efficient in vivo mammalian neuron editing using peptide-mediated CRISPR enzyme delivery
Brigette D. Manohar, Meika Travis, … Ross C. Wilson·bioRxiv·Nov 26, 2025
- Genetic editing of primary human dorsal root ganglion neurons using CRISPR-Cas9 with functional confirmation
Seph M. Palomino, Katherin A. Gabriel, … Amol M. Patwardhan·bioRxiv·Apr 2, 2024
- OASIS: in vivo AAV-mediated transduction and genome editing of adult oligodendrocytes
Xiaoyun Ding, Jackson R. Curtis, … Matthew Neil Rasband·bioRxiv·Oct 20, 2025